Using high frequency energy to treat nail fungus
Using Targeted, Controlled High Frequency Energy for Treatment of Onychomycosis
This study is testing a new, drug-free treatment for nail fungus that uses a special device to deliver gentle energy to help get rid of the infection, making it a safer option for people suffering from this common condition.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Accure Medical, LLC NIH-funded |
| Lab location | 1 site (Brookfield, United States) |
| Project ID | NIH-11065825 on NIH RePORTER |
What this research studies
This research investigates a new treatment for onychomycosis, a painful fungal infection of the nails that affects millions of people. The approach involves using targeted, controlled high frequency energy to eliminate the infection without the use of drugs, which can have harmful side effects. Patients will be treated with a device called TherawaveTM 100, designed to deliver precise energy levels to effectively target the fungi responsible for the infection. This method aims to provide a safer and more effective alternative to current drug-based treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from onychomycosis, particularly those who have not responded well to traditional antifungal medications.
Not a fit: Patients who do not have onychomycosis or those with other nail disorders unrelated to fungal infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safe, effective, and drug-free treatment option for patients suffering from onychomycosis.
How similar studies have performed: While the use of high frequency energy for treating infections is a novel approach, similar methods have shown promise in other areas of medical treatment.
Where this research is happening
Brookfield, United States
- Accure Medical, LLC — Brookfield, United States (Active)
Researchers
- Principal investigator: King, Laura — Accure Medical, LLC
- Study coordinator: King, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.